Latest California Healthline Stories
Podcast: ‘What The Health?’ Farewell, Individual Mandate
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Margot Sanger-Katz of The New York Times discuss health issues in the emerging tax bill, including the likely repeal of fines for those who fail to obtain health insurance. They also talk about the end of “open enrollment” for 2018 individual health insurance coverage.
Experts Tell Congress How To Cut Drug Prices. We Give You Some Odds.
Some of the nation’s most influential scientists recommend eight steps to lower drug prices. KHN takes the political temperature and tells you the chances of Congress acting on them.
Sen. Collins’ Strategy To Stabilize Insurance Market Raises Doubts Among Analysts
Even if the Republican from Maine can get her party to go along, her suggestions to bolster the individual insurance market may be too little, too late.
Podcast: ‘What The Health?’ Is Health Care Spending Still The Hungry, Hungry Hippo?
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of the Wall Street Journal, Alice Ollstein of Talking Points Memo and Margot Sanger Katz of The New York Times discuss new health spending numbers from the federal government, as well as how the year-end legislating in Congress is being complicated by health issues.
With CHIP In Limbo, Here Are 5 Takeaways On The Congressional Impasse
The sticking point is not whether to keep the popular Children’s Health Insurance Program running but how best to raise the cash. California, which leads the nation in CHIP enrollment, will run out of money within weeks.
Congress Isn’t Really Done With Health Care — Just Look At What’s In The Tax Bills
Even though congressional Republicans set aside their Obamacare repeal-and-replace efforts this year, here are five major health policy changes that could become law as part of the pending House and Senate proposals.
Patients With Rare Diseases And Congress Square Off Over Orphan Drug Tax Credits
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs” used to treat rare diseases, but patients are fighting against the plan.
Pressure Builds To Cut Medicare Patients In On Prescription Deals
Medicare officials have been discussing a rule change that would give beneficiaries a share of the secretive fees and discounts that are negotiated for prescription drugs.
House Republicans Aim To Yank Tax Credits For Orphan Drugs
House Republicans want to repeal federal tax credits that have helped spur a boom in orphan drugs for rare diseases.
House Tax Bill Would Scrap Deduction For Medical Expenses
About 9 million people claimed about $87 billion in medical deductions in 2015.